Acriflavine
- Molecular formula
- C27H33N6Cl2
- CAS Number
- 8063-24-9
- IUPAC Name
- dimethyl-[3-[(1-nitroacridin-9-yl)ammonio]propyl]ammonium;dichloride
- Molecular Weight
- 327.25g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.1000g/cm3
- Synonyms
- Ledakrin
Identification
Interesting Facts about Dimethyl-[3-[(1-Nitroacridin-9-yl)ammonio]propyl]ammonium Dichloride
This fascinating compound, known as Dimethyl-[3-[(1-nitroacridin-9-yl)ammonio]propyl]ammonium dichloride, belongs to a unique class of chemical structures that often play vital roles in medicinal chemistry and biological applications.
Unique Structural Features
- Ammonium Group: The presence of the ammonium group in the structure provides interesting properties, as it can engage in hydrogen bonding, which is crucial for interaction with biological molecules.
- Nitroacridine Moiety: The inclusion of a nitroacridine component suggests potential applications in cancer therapies, as acridine derivatives are known to exhibit antitumor activities.
- Dimethylation: The dimethyl groups enhance solubility and biological activity, making this compound potentially useful in various pharmaceutical formulations.
Potential Applications
This compound is not just a chemical curiosity; it has potential implications in various fields:
- Anticancer Research: Due to its structural resemblance to known chemotherapeutic agents, it may have significant anticancer properties that warrant further investigation.
- Biological Studies: It can serve as a probe in studying cellular mechanisms, especially in cancer cells, assisting scientists in understanding drug effectiveness.
- Developing Novel Therapeutics: The unique chemical properties could make it a candidate for designing new medicines targeting specific pathways in cancer treatment.
Research Opportunities
Research involving this compound could yield valuable insights. Areas of exploration might include:
- Mechanisms of action against various types of cancer cells.
- Synergistic effects when used in combination with other chemotherapeutic agents.
- The development of drug delivery systems tailored to enhance efficacy and reduce side effects.
In conclusion, Dimethyl-[3-[(1-nitroacridin-9-yl)ammonio]propyl]ammonium dichloride represents a promising intersection of chemistry and pharmacology, emphasizing the need for continued exploration to fully harness its potential.